LUTONIX
Lutonix DCB is a new drug-coated balloon catheter that delivers paclitaxel to the arterial wall in a single, short inflation. Paclitaxel is an anti-proliferative drug commonly used to prevent arterial restenosis. Lutonix DCB is very similar to a standard angioplasty balloon, but contains a special coating consisting of paclitaxel and a proprietary carrier that facilitates the drug’s transfer to the arterial wall upon inflation. This highly efficient formulation allows Lutonix DCB to deliver a therapeutic dose to the artery wall, while keeping the dose of paclitaxel on the balloon as low as possible. A lower balloon drug load minimizes systemic drug exposure and is designed to maximize safety.
LUTONIX
Industry:
Biotechnology Health Care Medical Device
Founded:
2007-01-01
Address:
Maple Grove, Minnesota, United States
Country:
United States
Website Url:
http://www.lutonix.com
Total Employee:
11+
Status:
Active
Contact:
763-445-2352
Email Addresses:
[email protected]
Total Funding:
35 M USD
Technology used in webpage:
Microsoft Azure DNS Liquid Web MarkMonitor DNS
Similar Organizations
Kintai Therapeutics
Kintai is a biotechnology company that advancing precision therapeutics based on enteric signaling networks in the human body.
Current Employees Featured
Founder
Investors List
Delphi Ventures
Delphi Ventures investment in Series B - Lutonix
U.S. Venture Partners
U.S. Venture Partners investment in Series B - Lutonix
RiverVest
RiverVest investment in Series B - Lutonix
Versant Ventures
Versant Ventures investment in Series B - Lutonix
Official Site Inspections
http://www.lutonix.com
- Host name: aeedc42b70c898c66.awsglobalaccelerator.com
- IP address: 3.33.139.32
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Lutonix"
Lutonix - Crunchbase Company Profile & Funding
Lutonix DCB is a new drug-coated balloon catheter that delivers paclitaxel to the arterial wall in a single, short inflation. Paclitaxel is an anti-proliferative drug …See details»
Lutonix, Inc. Company Profile | Tempe, AZ - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Lutonix, Inc. of Tempe, AZ. Get the latest business insights from Dun & Bradstreet.See details»
Lutonix Inc - Company Profile and News - Bloomberg Markets
Company profile page for Lutonix Inc including stock price, company news, executives, board members, and contact informationSee details»
Lutonix™ Drug Coated Balloon PTA Catheters | BD
The Lutonix™ Drug Coated Balloon PTA Catheter is offered in 0.018 and 0.035 guidewire configurations for the treatment of de novo, restenotic, or in-stent restenotic lesions in the …See details»
Lutonix - Products, Competitors, Financials, Employees, …
Lutonix is a medical device company developing drug-coated balloon catheters for the treatment of vascular disease. In December 2011, Lutonix was acquired by C.R. Use the CB Insights …See details»
Lutonix 2025 Company Profile: Valuation, Investors, Acquisition
Information on acquisition, funding, cap tables, investors, and executives for Lutonix. Use the PitchBook Platform to explore the full profile.See details»
Lutonix, Inc. - Rivervest
Founded in part by RiverVest, Lutonix developed the first FDA-approved drug-coated angioplasty balloon catheter that delivers paclitaxel to the arterial wall when used for the treatment of …See details»
Lutonix Company Profile -Sales, Contacts, Competitors – Buzzfile
Lutonix is located in Tempe, Arizona. This organization primarily operates in the Surgical and Medical Instruments business / industry within the Measuring, Photographic, Medical, & …See details»
Lutonix Company Profile - Office Locations, Competitors ... - Craft
See insights on Lutonix including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Lutonix, Inc - VentureRadar
Developing a novel catheter system to treat coronary and peripheral arterial stenosis caused by atherosclerosis. ... Find out more about Lutonix, Inc, Health Care.See details»
Lutonix - Overview, News & Similar companies | ZoomInfo.com
View Lutonix (www.lutonixdcb.com) location in Minnesota, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Lutonix - Ownership and Business Overview - Mergr
Where is Lutonix headquartered? Lutonix is headquartered in New Hope, Minnesota. What sector is Lutonix in? Lutonix is a medical products company. When was Lutonix founded? Lutonix …See details»
Bard Acquires Lutonix, Inc. - TCTMD.com
Dec 20, 2011 MURRAY HILL, NJ -- C. R. Bard, Inc. today announced that it has acquired Lutonix, Inc. for a purchase price of approximately $225 million paid at closing, with an …See details»
Lutonix - Funding, Financials, Valuation & Investors - Crunchbase
Lutonix DCB is a new drug-coated balloon catheter that delivers paclitaxel to the arterial wall in a single, short inflation.See details»
BD to shutter Minnesota Lutonix plant, layoffs ahead for 53
Oct 10, 2019 Becton Dickinson (NYSE: BDX) is planning to close a Minnesota plant that makes its Lutonix drug-coated balloon next year, as the company looks to consolidate its peripheral …See details»
Lutonix Announces Achievement of Significant Milestones and …
Jun 28, 2011 Lutonix is the first company to receive approval from the FDA to initiate a drug-coated balloon trial. The company also announced two new additions to its leadership team.See details»
BD-63949 Lutonix Go Brochure
The Lutonix Global Registry showed sustained eficacy of LutonixTM 035 DCB in heterogeneous patient population in real-world clinical practice.5 The primary eficacy endpoint was measured …See details»
FDA Approves Lutonix 035: First Drug-Coated Balloon for ... - PTCA
The Lutonix® 035 DCB—the first and only FDA-approved DCB in the U.S.— is an angioplasty balloon coated with a therapeutic dose of the drug paclitaxel, and also utilizes standard …See details»
The 24-Month Results of the Lutonix Global SFA Registry:
Objectives: The Global SFA Registry sought to assess safety, clinical benefit, and outcomes of the Lutonix 035 drug-coated balloon (DCB) in a heterogeneous, real-world patient population …See details»
Leading with - BD
The primary objective of the Lutonix Global Registry was to demonstrate safety and assess the clinical use and outcomes of the LutonixTM DCB for treatment of below-the-knee arteries in a …See details»